NSW Premier Gladys Berejiklian announces further funding for Meningococal Adolesent ACWY program

Thousands more NSW students will be offered the free meningococcal vaccine in the next 12 months to protect them against the debilitating disease.

As the NSW Government launches its awareness campaign this week, Premier Gladys Berejiklian today announced a further $3.6 million to extend the NSW Meningococcal W Response Program, which has provided free vaccine to more than 200,000 teenagers to date.

The NSW Government has invested $17 million into the statewide program since it was introduced in 2017 to protect teenagers against the rising threat of the W strain, which has an eight per cent mortality rate compared to four per cent for other strains.



Ferguson announces Tasmanian vaccination program

After 5 diagnosed cases of Meningococal disease in Tasmania over the past 2 weeks, Today Michael Ferguson will today announce that all children and young adults under 21 as of the 1st of August 1997 will able to access free ACWY vaccines.

This is welcome news as 4 out of the 5 cases have been the W strain of Meningococal disease.

Well done Tasmanian government for acting on this so promptly.


For any inquires contact Eliza 0499092702

Meningococcal B vaccine program commencing in South Australia October 1st2018

Fantastic news announced that the South Australian government will be introducing a Meningococal B vaccination program in October 0f 2018. This comprehensive program will not only vaccinated babies for the disease but also children up to age 4 and adolescents in the early part of 2019.

More detailed information regarding be found here


Meningococcal Disease vaccine trials

There are currently trials for Meningococal vaccines happening in Australia in Adelaide and Melbourne.

These trials are for healthy 18-50 year olds that fit the selected criteria.


Please contact the below for further information

Adelaide- CMAX clinical research 1800 150 443

Melbourne- Center for clinical studies 1800 243 733 or reply@nucleusnetwork.com.au


Information for families travelling to Fiji where there is a Men C outbreak

We are receiving daily questions about the Meningococcal C disease outbreak in Fiji, and how Australian families can get protected before they travel.

In 2003 the Meningococcal C vaccine was introduced on the Australian NIP (for babies at 12 months of age). Since then, there have seen a massive reduction in the number of cases of serogroup C Meningococcal disease in Australia.

Some families are concerned about traveling to Fiji during this out break. Please speak to your GP or travel Doctor prior to travel if you have a child under 12 months of age who hasn't had their NIP Meningoccocal C vaccine. There are other ACWY vaccines available that can help to protect your child as well as other family members.

Fortunately for Fiji residents a vaccination program will be taking place in the coming months to help combat the disease.

Please refer to the websites below with vaccine travel advice



NEW Meningococcal B vaccine availible in Australia

A new vaccine to provide teens and young adults protection against a deadly strain of meningococcal disease has been launched in Australia.

The meningococcal B vaccine Trumenba is now available for the immunisation of people 10 years and older,  made by manufacturer Pfizer.

While rare, meningococcal disease can strike without warning, killing up to one in ten, and leaving up to a third of survivors with damaging after-effects ranging from psychological disorders to loss of limbs.

For the past 30 years meningococcal group B (MenB) has been one of the most prevalent strains of the disease in Australia.

Professor Robert Booy, Head of Clinical Research at the National Centre for Immunisation Research and Surveillance (NCIRS) warns the disease has become more common in the last three years.


ACWY vaccine announcment by Greh Hunt MP

It has been announced today that the ACWY quad vaccine will be added to the NIP in July. This is amazing news that babies at 12 months of age will receive this vaccine protecting them against 4 strains of Meningococcal disease.

Media - to arrange an interview contact Eliza 0499092702 or info@meningococcal.org.au


TGA approves MENVEO vaccine to help protect babies from 2 months of age from Meningococcal disease

A Welcome relief to parents of babies today as GSK announces that MENVEO,  (a combination   ACWY vaccine) is available for use in babies from 2 months of age.

This is an significant announcement as we move into our peak season for this disease.

Meningococcal W strain has doubled in number of cases in the last 18 months and is now one of the more prevalent strains in Australia- alongside A,B, C, X and Y. This vaccination is NOT on the National Immunisation Schedule - please speak to your GP about this vaccination.


For media enquirers please contact Eliza Ault- Connell 0499092702

NIP and meningococcal vaccines

There has been many articles on social media over the last few days that have stated that new meningococcal vaccines are being added to the NIP.

This is unconfirmed information. We have been actively involved in advocating inclusion to parliament. We are hoping to hear in the coming days if this plan is to be made official.

South Australia experiencing a 6 year high with Meningococcal rates

Meningococcal Cases In SA Hit Six Year High

Meningococcal cases in SA have hit a 6 year high.

There have been 20 cases reported in the State so far this year compared to 13 this time in 2016.

Back in 2012 there were 14 cases.

This is deeply concerning news- not only children have been affected, adults in their 30s-50's have been affected. This comes after the passing of a man in his 50's only last month from Meningococcal B strain.


Awareness of early signs and symptoms as well as vaccination is critical.


For media enquirers contact Meningococcal Australia - 0499092702


For further information please click here http://www.meningococcal.org.au/new-page-1/

More postive news for teen's and Meningococcal Disease

4 States will now be offering ACWY vaccines for teenagers.

Yesterday it was announced that QLD will join WA, NSW and Victoria in vaccinating teenagers 15-19 years for Meningoccocal disease- in direct response to the rise inMeningococcal W strain over the last 12-18 months.

This will have an incredible impact, however a federal approach is still needed to combat this disease. This disease knows no boundaries, and a consistent and equal approach is required.


For media enquires please call 0499092702

Up to 60,000 South Australian students to be offered Meningococcal B vaccines

Over a 2 year period up to 60,000 SA students between Year 10, 11 and 12 students across the state will be eligible to participate in the study if their school signs up and parents and students provide consent. This program is set to begin in 2017 and conclude in 2018.

The aim of this ambitious project is to test in the the 'herd immunity' in theteenage population. It will not only vaccinate a person, but will also prevent the individual from carrying or spreading it to others.

To find out more please visit http://www.bpartofit.com.au/about


2016 Meningococcal Statistics year to date statistics

Looking at the statistics of Meningococcal disease so far in 2016 looks to be proportionally high in some particular states.

In States where data is available we can see that:

In Victoria there has been 57 cases YTD ( year to date, so far this year) 2016, up from 50 cases in 2015, and 26 cases in 2014.

In NSW, a similar story 63 cases YTD 2016, up from 43 in 2015 and 35 in 2014. Importantly to note, 39 cases have been from strains OTHER than B or C.

WA has had 17 cases YTD 2016, 17 in 2015, and 17 in 2014.

Further information can be found here. KNOW, CHECK and Act for Meningococcal Disease.






Increase in Meningococcal disease W strain

Meningococcal disease due to the W strain has been increasing in Australia, affecting babies, young children teenagers and young adults. It can be very serious. At present there is no vaccine funded by government to prevent W disease. The most common strain of Meningococcal disease is B strain. The government has been considering weather to introduce that vaccination into the schedule for babies/children. Such a vaccine may also prevent W disease as the B vaccine is a cross.

Meningococcal Disease B vaccine Petition

The Parkyn Family in South Australia started this petition after their 3 year old daughter Jazmyn was diagnosed with Meningococcal B back in August 2015. Her parents had Jazmyn (and her 2 siblings) 'fully' immunised under the free Australian Immunisation program. Jazmyn's parents assumed that they were protected for Meningococcal Disease.

 Meningococcal B is the most common strain in Australia today.  Currently, the meningococcal C vaccine is on the schedule, and the B vaccine is only available on the private market. This can be unaccessible for many families.

 Meningococcal Australia are helping the Parkyn family reach and educate as many people as they can, which will in turn assist this important vaccine being added to the National immunisation program.  If you wish to have this petition in your workplace, business or school, please contact Meningococcal Australia info@meningococaal.org.au. 

Your support is vital.  Together, we can make a difference and have our voices heard.

Meningococcal B vaccine rejected by PBAC July 15 meeting

Meningococcal Australia is disappointed to learn that the Meningococcal B vaccine has not been successful in gaining PBS status. This means that Australian families will have to continue to source the vaccine on the private market and pay from their own pocket. We are disappointed that the committee has made this decision, this vaccine should be accessible for all children on the NIP (National Immunisation Program). Meningococcal B is now the most prevalent strain in Australia today. Since the successful introduction of the Meningococcal C vaccine back in 2003, it has had such a positive result protecting our whole community. We hope hope that the concerns around the vaccines implementation can be addressed in the coming months and we can see the Men B vaccine added to protect our community. Until then please remember to Know, Check and Act for Meningococcal Disease.

Peak Season Alert

Late winter and early Spring herald the peak time for Meningococcal Disease cases. We have been fortunate to have had great media coverage helping to educate the public on the KNOW, CHECK and ACT message in resent weeks however Meningococcal Disease is still within our community and we need more awareness around early detection and well as vaccination.